Compare · AFAC vs MCK
AFAC vs MCK
Side-by-side comparison of Arena Fortify Acquisition Corp. (AFAC) and McKesson Corporation (MCK): market cap, price performance, sector, and recent activity on the wire.
Summary
- AFAC operates in Miscellaneous, while MCK operates in Health Care - the two are in different parts of the market.
- MCK is the larger of the two at $116.43B, about 544.3x AFAC ($213.9M).
- MCK has hit the wire 4 times in the past 4 weeks while AFAC has been quiet.
- MCK has more recent analyst coverage (25 ratings vs 0 for AFAC).
- Company
- Arena Fortify Acquisition Corp.
- McKesson Corporation
- Price
- $10.29+0.29%
- $1005.29+0.65%
- Market cap
- $213.9M
- $116.43B
- 1M return
- -
- +14.29%
- 1Y return
- -
- +27.82%
- Industry
- Other Pharmaceuticals
- Other Pharmaceuticals
- Exchange
- NASDAQ
- NYSE
- IPO
- 2021
- News (4w)
- 0
- 4
- Recent ratings
- 0
- 25
Arena Fortify Acquisition Corp.
Arena Fortify Acquisition Corp. focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on acquisition candidates within the natural resources industry. The company was incorporated in 2021 and is based in New York, New York.
McKesson Corporation
McKesson Corporation provides healthcare supply chain management, retail pharmacy, community oncology and specialty care, and healthcare information solutions in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment offers CoverMyMeds solution to help patients get the medications; RelayHealth, a workflow solution; RxCrossroads solution for therapies and interventions to biopharma manufacturers; and McKesson Prescription Automation, a customized pharmacy automation technology; and Multi-Client Central Fill as a Service, a pharmacy. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
Latest AFAC
- SEC Form SC 13G/A filed by Arena Fortify Acquisition Corp. (Amendment)
- SEC Form SC 13G/A filed by Arena Fortify Acquisition Corp. (Amendment)
- SEC Form SC 13G/A filed by Arena Fortify Acquisition Corp. (Amendment)
- SEC Form 4 filed by Arena Fortify Sponsor Llc
- SEC Form 15-12G filed by Arena Fortify Acquisition Corp.
- Arena Fortify Acquisition Corp. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits
- Arena Fortify Acquisition Corp. Obtains Stockholder Approval to Terminate Before Year-End
- SEC Form 25-NSE filed by Arena Fortify Acquisition Corp.
- SEC Form 25-NSE filed by Arena Fortify Acquisition Corp.
- SEC Form 25-NSE filed by Arena Fortify Acquisition Corp.
Latest MCK
- SEC Form 8-K filed by McKesson Corporation
- CD&R and McKesson Corporation Sign Agreement to Acquire Option Care Health
- McKesson Corporation Extends Pharmaceutical Distribution Agreement with CVS Health
- McKesson Corporation Announces Second Quarter Fiscal 2027 Earnings Release Date
- SVP, Controller & CAO Rutledge Napoleon B Jr sold $98,951 worth of shares (111 units at $891.45) as part of a pre-agreed trading plan, decreasing direct ownership by 18% to 521 units (SEC Form 4)
- McKesson Corporation filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- McKesson Signs Agreement to Acquire Precision Medicine Group, LLC
- RBC Capital Mkts initiated coverage on McKesson with a new price target
- SEC Form 4 filed by EVP and Chief Strategy Officer Srinivasan Ramesh (Nmn)
- Director Lerman Bradley E sold $268,590 worth of shares (301 units at $892.33), closing all direct ownership in the company (SEC Form 4)